Harvard Apparatus Regenerative Technology, Inc. (HRGN) stock
HRGNOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$2.21−0.02 (-0.72%)
Close on Oct 19, 2026Market cap $38.92MP/E –Yield –
Harvard Apparatus Regenerative Technology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Harvard Apparatus Regenerative Technology's revenue for the twelve months ending Jun 30, 2026 was $982.00K, up 44.6% year over year. For fiscal 2025 it was $704.00K, up 63.7% from the year before. Over ten years it grew 22.4% a year on average. The highest annual figure on record is $704.00K in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $704.00K | +63.7% |
| FY2024 | Dec 31, 2024 | $430.00K | +317.5% |
| FY2023 | Dec 31, 2023 | $103.00K | – |
| FY2021 | Dec 31, 2021 | $0 | – |
| FY2020 | Dec 31, 2020 | $0 | – |
| FY2019 | Dec 31, 2019 | $0 | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | -100.0% |
| FY2016 | Dec 31, 2016 | $82.00K | -30.5% |
| FY2015 | Dec 31, 2015 | $118.00K | +26.9% |
| FY2014 | Dec 31, 2014 | $93.00K | +322.7% |
| FY2013 | Dec 31, 2013 | $22.00K | – |
| FY2012 | Dec 31, 2012 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $414.00K | +30.6% |
| Q1 FY2026 | Mar 31, 2026 | $226.00K | +402.2% |
| Q4 FY2025 | Dec 31, 2025 | $219.00K | -15.1% |
| Q3 FY2025 | Sep 30, 2025 | $123.00K | +108.5% |
| Q2 FY2025 | Jun 30, 2025 | $317.00K | +466.1% |
| Q1 FY2025 | Mar 31, 2025 | $45.00K | -21.1% |
| Q4 FY2024 | Dec 31, 2024 | $258.00K | +309.5% |
| Q3 FY2024 | Sep 30, 2024 | $59.00K | +47.5% |
| Q2 FY2024 | Jun 30, 2024 | $56.00K | – |
| Q1 FY2024 | Mar 31, 2024 | $57.00K | – |
| Q4 FY2023 | Dec 31, 2023 | $63.00K | – |
| Q3 FY2023 | Sep 30, 2023 | $40.00K | – |
| Q2 FY2022 | Jun 30, 2022 | $0 | – |
| Q1 FY2022 | Mar 31, 2022 | $0 | – |
| Q4 FY2021 | Dec 31, 2021 | $0 | – |
| Q3 FY2021 | Sep 30, 2021 | $0 | – |
| Q2 FY2021 | Jun 30, 2021 | $0 | – |
| Q1 FY2021 | Mar 31, 2021 | $0 | – |
| Q4 FY2020 | Dec 31, 2020 | $0 | – |
| Q3 FY2020 | Sep 30, 2020 | $0 | – |
| Q2 FY2020 | Jun 30, 2020 | $0 | – |
| Q1 FY2020 | Mar 31, 2020 | $0 | – |
| Q4 FY2019 | Dec 31, 2019 | $0 | – |
| Q3 FY2019 | Sep 30, 2019 | $0 | – |
| Q2 FY2019 | Jun 30, 2019 | $0 | – |
| Q1 FY2019 | Mar 31, 2019 | $0 | – |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | -100.0% |
| Q3 FY2017 | Sep 30, 2017 | $0 | -100.0% |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $28.00K | – |
| Q3 FY2016 | Sep 30, 2016 | $26.00K | – |
See a number that looks wrong?